Citation Impact
Citing Papers
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
2011
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine Treatment
2008
Cabozantinib in Progressive Medullary Thyroid Cancer
2013
Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
2009
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
2017
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
2010
Immunotherapy of melanoma
2013
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay
2014
Smarter drugs emerging in pancreatic cancer therapy
2014
EGFR Antagonists in Cancer Treatment
2008 Standout
Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations
2007
Pancreatic Ductal Adenocarcinoma
2012
Adrenalectomy for Familial Pheochromocytoma in the Laparoscopic Era
2002
Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas
2010
Prognostic utility of BRAF mutation in papillary thyroid cancer
2009
Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability
2008
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
Pancreatic cancer
2004 Standout
Inoperable Symptomatic Recurrent Thyroid Cancers: Preliminary Result of Radiofrequency Ablation
2011
Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer
2010
Pheochromocytoma in multiple endocrine neoplasia type 2: European study
1995
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
2013
Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma
2013
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Thyroid cancer
2016 Standout
Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma
2005
The Clinical Presentation (Symptoms and Signs) of Sporadic and Familial Chromaffin Cell Tumours (Phaeochromocytomas and Paragangliomas)
2003
The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size
2007
Global Cancer Statistics, 2002
2005 Standout
Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
2013
Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
2008
Intraoperative Pathologic Examination in the Era of Molecular Testing for Differentiated Thyroid Cancer
2012
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
2011
Pancreatic cancer
2020 Standout
The Role of Venous and Arterial Resection in Pancreatic Cancer Surgery
2016
Screening for pancreatic cancer in familial high-risk individuals: A systematic review
2015
Laparoscopy and peritoneal cytology in the staging of pancreatic cancer
2000
Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples
2011
Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer
2010
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
2014
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review
2007
Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer
2010
Recent developments in the therapy of phaeochromocytoma
2004
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Renal-Cell Carcinoma
1996 Standout
BRAF mutation in thyroid cancer
2005
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2010
American Thyroid Association Statement on Preoperative Imaging for Thyroid Cancer Surgery
2014
Cost-effective Management of Low-Risk Papillary Thyroid Carcinoma
2007
Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.
1998
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Medullary Thyroid Carcinoma
2007
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma
2014
Surgeon Volume and Operative Mortality in the United States
2003 Standout
A prospective study of obesity and cancer risk (Sweden)
2001
The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a Summation
2008
Tumor Lymphangiogenesis
2003
Lymphangiogenesis in development and human disease
2005 StandoutNature
Pancreatic Adenocarcinoma
2014 Standout
Estimated Risk of Pheochromocytoma Recurrence After Adrenal-Sparing Surgery in Patients With Multiple Endocrine Neoplasia Type 2A
2006
Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas
2011
Preoperative Chemoradiation for Patients With Locally Advanced Adenocarcinoma of the Pancreas
1999
Pax-8–PPAR-γ fusion protein in thyroid carcinoma
2014
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
1997
Adrenal-preserving laparoscopic surgery in selected patients with bilateral adrenal tumors
2003
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis
2007
von Hippel-Lindau disease
2003 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma
2003
Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology
2013
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
Prophylactic Central Neck Dissection in Differentiated Thyroid Cancer: An Assessment of the Evidence
2013
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
2012
Cost-Effectiveness of a Novel Molecular Test for Cytologically Indeterminate Thyroid Nodules
2011
Effect of Hospital Volume on Surgical Outcomes After Pancreaticoduodenectomy
2015
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
Effect of Preoperative Biliary Decompression on Pancreaticoduodenectomy-Associated Morbidity in 300 Consecutive Patients
2001
Strategies for early detection of resectable pancreatic cancer
2014
Patient Perception of a Clinical Pathway for Laparoscopic Foregut Surgery
2006
Malignant Gliomas in Adults
2008 Standout
Post‐thyroid FNA testing and treatment options: A synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference
2008
Outcomes of Adjuvant Chemoradiation After Pancreaticoduodenectomy With Mesenterico-Portal Vein Resection for Adenocarcinoma of the Pancreas
2009
The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy
2011
Sonographically‐Directed Neck Dissection for Recurrent Thyroid Carcinoma
2008
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy
2003
Polymorphisms in the p53 pathway
2006
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer
2008
Cystic Lymph Nodes in the Lateral Neck As Indicators of Metastatic Papillary Thyroid Cancer
2010
Risk‐Oriented Approach to Hereditary Adrenal Pheochromocytoma
2006
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
Arterial and Venous Resection for Pancreatic Adenocarcinoma
2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation
2009
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Ultrasound-Guided Fine Needle Biopsy of Pancreatic Masses: Results of a Multicenter Study
1998
Pancreatic Cancer
2010 Standout
The Role of BRAFV600E Mutation and Ultrasonography for the Surgical Management of a Thyroid Nodule Suspicious for Papillary Thyroid Carcinoma on Cytology
2009
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Case-Control Study of Non-Hodgkin's Lymphoma among Women and Heterosexual Men in the San Francisco Bay Area, California
1999
A Meta-analysis of the Effect of Prophylactic Central Compartment Neck Dissection on Locoregional Recurrence Rates in Patients with Papillary Thyroid Cancer
2013
Value of Preoperative Ultrasonography in the Surgical Management of Initial and Reoperative Papillary Thyroid Cancer
2006
Management of Recurrent/Persistent Nodal Disease in Patients with Differentiated Thyroid Cancer: A Critical Review of the Risks and Benefits of Surgical Intervention Versus Active Surveillance
2014
Overweight as an avoidable cause of cancer in Europe
2001
Nutrition and renal cell cancer
1996
Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer
2015
Cushing's syndrome
2006 Standout
Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation
2007
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Management and Treatment of Pheochromocytomas and Paragangliomas
2006
Molecular genetics and diagnosis of thyroid cancer
2011
Nutrition and prostate cancer
1996
Adjuvant therapy for high‐risk primary and resected metastatic melanoma
2003
Hepatocellular Carcinoma
2011 Standout
Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma
2010
Extent of adrenalectomy for adrenal neoplasm: cortical sparing (subtotal) versus total adrenalectomy
2004
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
2011 Nature
Is Surgery Getting Safer? National Trends in Operative Mortality1,2
2002
Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome
2012
Angiogenesis as a therapeutic target
2005 StandoutNature
Does Postoperative Thyrotropin Suppression Therapy Truly Decrease Recurrence in Papillary Thyroid Carcinoma? A Randomized Controlled Trial
2010
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Pancreatic cancer
2011 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
2004
Controversies in the Surgical Management of Newly Diagnosed and Recurrent/Residual Thyroid Cancer
2009
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
2012
A Large Multicenter Correlation Study of Thyroid Nodule Cytopathology and Histopathology
2010
The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution
2009
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
A Diagnostic Predictor Model for Indeterminate or Suspicious Thyroid FNA Samples
2008
The Impact of Assessing Specimen Adequacy and Number of Needle Passes for Fine-Needle Aspiration Biopsy of Thyroid Nodules
2006
Preoperative Diagnosis of Cervical Metastatic Lymph Nodes in Papillary Thyroid Carcinoma: Comparison of Ultrasound, Computed Tomography, and Combined Ultrasound with Computed Tomography
2008
In Papillary Thyroid Cancer, Preoperative Central Neck Ultrasound Detects Only Macroscopic Surgical Disease, But Negative Findings Predict Excellent Long-Term Regional Control and Survival
2012
BRAF : A Tool in the Decision to Perform Elective Neck Dissection?
2012
Advances in Ultrasound for the Diagnosis and Management of Thyroid Cancer
2009
The Diagnostic Accuracy of Ultrasound-Guided Fine-Needle Aspiration Biopsy and the Sonographic Differences Between Benign and Malignant Thyroid Nodules 3 cm or Larger
2011
Thyroid Fine-Needle Aspiration Biopsy: Variability in Reporting
2009
Surgeon-Performed Ultrasound in the Management of Thyroid Malignancy
2004
Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China.
1997
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Central Lymph Node Dissection in Differentiated Thyroid Cancer
2007
The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer
2013
Medullary Thyroid Carcinoma: Management of Lymph Node Metastases
2010
A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
2013
Serum Thyroglobulin, High-Resolution Ultrasound, and Lymph Node Thyroglobulin in Diagnosis of Differentiated Thyroid Carcinoma Nodal Metastases
2007
Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
2009
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Pheochromocytoma: implications in tumorigenesis and the actual management.
2012
Value of the Cervical Compartments in the Surgical Treatment of Papillary Thyroid Carcinoma
2004
Preoperative Staging of Papillary Thyroid Carcinoma: Comparison of Ultrasound Imaging and CT
2009
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Adjuvant Treatment for Resectable Pancreatic Cancer
2005
Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers
2007
Management of Low-Risk Differentiated Thyroid Cancer
2007
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
LAPAROSCOPIC PARTIAL ADRENALECTOMY IN PATIENTS WITH HEREDITARY FORMS OF PHEOCHROMOCYTOMA
2000
The Two Faces of Interferon-γ in Cancer
2011
Pheochromocytoma: State-of-the-Art and Future Prospects
2003
Partial Adrenalectomy: Underused First Line Therapy for Small Adrenal Tumors
2010
Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer
2001
Evaluation of Postoperative Radioactive Iodine Scans in Patients who Underwent Prophylactic Central Lymph Node Dissection
2012
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial
2004
Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer
2008
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
2014
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
2007
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
2012
Adrenal-sparing surgery for phaeochromocytoma
1999
Benign and Malignant Pheochromocytoma
1998
Guidelines for the management of thyroid cancer
2014 Standout
Preoperative Biliary Drainage for Cancer of the Head of the Pancreas
2010
Update in Utility of Secondary Node Dissection for Papillary Thyroid Cancer
2012
Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients
2013
Functional and Oncologic Outcomes of Partial Adrenalectomy for Pheochromocytoma in Patients With von Hippel-Lindau Syndrome After at Least 5 Years of Followup
2010
Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? a meta-analysis of the literature
2013
Diagnostic Accuracy of CT and Ultrasonography for Evaluating Metastatic Cervical Lymph Nodes in Patients with Thyroid Cancer
2008
LAPAROSCOPIC SURGERY FOR PHEOCHROMOCYTOMA: ADRENALECTOMY, PARTIAL RESECTION, EXCISION OF PARAGANGLIOMAS
1998
Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules: A Decision Analytic Approach
2014
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
2019
Level VI Lymph Node Dissection Does Not Decrease Radioiodine Uptake in Patients Undergoing Radioiodine Ablation for Differentiated Thyroid Cancer
2012
Tumortyp- und tumorstadienorientiertes chirurgisches Konzept bei Karzinomen der Schilddrüse
2010
Dual-Phase Helical CT of Pancreatic Adenocarcinoma
2002
Pheochromocytomas and Paragangliomas in von Hippel–Lindau Disease
2002
Thyroid carcinoma
2003 Standout
Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma
2001
Height, body weight, and risk of prostate cancer.
1997
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
2005
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules
2009
Laparoscopy in the staging of pancreatic cancer
2001
Works of Jeffrey E. Lee being referenced
Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?
2010
Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma
2011
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma
2010
Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy
2012
Surgical management, DNA content, and patient survival in adrenal cortical carcinoma
1995
Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head
1995
Surgical Strategy for the Treatment of Medullary Thyroid Carcinoma
1999
Metastatic melanoma to lymph nodes in patients with unknown primary sites
2006
Reoperative pancreaticoduodenectomy for periampullary carcinoma
1996
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
2012
Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy
2012
Current Approaches and Future Strategies for Pancreatic Carcinoma
2000
Rationale for En Bloc Vein Resection in the Treatment of Pancreatic Adenocarcinoma Adherent to the Superior Mesenteric-Portal Vein Confluence
1996
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
2008
Delayed Recovery after Pancreaticoduodenectomy: A Major Factor Impairing the Delivery of Adjuvant Therapy?
2007
The Need for Standardized Pathologic Staging of Pancreaticoduodenectomy Specimens
1996
Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?
2007
Cost and Utilization Impact of a Clinical Pathway for Patients Undergoing Pancreaticoduodenectomy
2000
Routine pre-operative ultrasonography for papillary thyroid cancer: Effects on cervical recurrence
2009
Posterior Retroperitoneoscopic Adrenalectomy: A Contemporary American Experience
2011
Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
2010
Limitations of size as a criterion in the evaluation of adrenal tumors
2000
p53 Codon 72 Arg Homozygotes Are Associated with an Increased Risk of Cutaneous Melanoma
2003
Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis
1999
Significance of Plasma Cytokine Levels in Melanoma Patients With Histologically Negative Sentinel Lymph Nodes
2001
Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas
1998
Pancreaticoduodenectomy After Placement of Endobiliary Metal Stents
2005
Venous resection in pancreatic cancer surgery
2006
Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality
2015
Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography
2006
Streamlining variability in hospital charges for standard thyroidectomy: Developing a strategy to decrease waste
2014
Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
2007
Preventable reoperations for persistent and recurrent papillary thyroid carcinoma
2004
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
2006
Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma
1996
Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer
2016
Pancreaticoduodenectomy with vascular resection: margin status and survival duration
2004
Optimal treatment strategy in patients with papillary thyroid cancer: A decision analysis
2001
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
2009
Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration
2001
Surgical management of hereditary pheochromocytoma1
2004
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer
2003
Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head
1996
Followup of Patients with Papillary Thyroid Cancer: In Search of the Optimal Algorithm
2007
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
2013
Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: Practice patterns of endocrine surgery
2006
Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients
2003
Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification
2013
Role for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Thick (?4 mm) Primary Melanoma
2000
Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients
2003
RET Proto-Oncogene: A Review and Update of Genotype–Phenotype Correlations in Hereditary Medullary Thyroid Cancer and Associated Endocrine Tumors
2005
Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients
1999
Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome
2002
Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1
2006
Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
2008
Early Precursors of Site-Specific Cancers in College Men and Women<xref ref-type="fn" rid="FN2">2</xref>
1985
778 Morbidity and Mortality After Pancreaticoduodenectomy in Patients With Borderline Resectable Type C Clinical Classification
2013
Adrenal Medullary Disease in Multiple Endocrine Neoplasia Type 2: Appropriate Management
1994
No Association between Parkinson Disease Alleles and the Risk of Melanoma
2012
Early Precursors of Urogenital Cancers in Former College Men
1984
Long-Term Outcomes of Surgical Treatment for Hereditary Pheochromocytoma
2013
Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
2008
Adrenal cortical carcinoma
2001
Abdominal Visceral Lesions in von Hippel‐Lindau Disease: Incidence and Clinical Behavior of Pancreatic and Adrenal Lesions at a Single Center
2006
Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique.
1996
Neoadjuvant Chemoradiation for Adenocarcinoma of the Pancreas
1998
Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression
2011
Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy
2011
Diagnostic Accuracy of Endoscopic Ultrasound–Guided Fine-Needle Aspiration in Patients With Presumed Pancreatic Cancer
2003
Surgical Management of Thyroid Carcinoma
2005
Preoperative Chemoradiation for Patients With Pancreatic Cancer: Toxicity of Endobiliary Stents
2000
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
2001
Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic Cancer
2006